MedPath

LABORATOIRES THEA

🇫🇷France
Ownership
-
Established
1994-01-01
Employees
-
Market Cap
-
Website
http://www.laboratoires-thea.com/

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Phase 4
Completed
Conditions
Primary Open Angle Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2013-12-20
Last Posted Date
2020-04-02
Lead Sponsor
Laboratoires Thea
Target Recruit Count
379
Registration Number
NCT02017327
Locations
🇫🇷

Laboratoires Théa, Clermont ferrand, France

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Phase 3
Completed
Conditions
Keratitis
Corneal Ulcer
Interventions
Device: T4020
Device: Vehicle
First Posted Date
2013-02-18
Last Posted Date
2019-10-23
Lead Sponsor
Laboratoires Thea
Target Recruit Count
152
Registration Number
NCT01794312
Locations
🇫🇷

Clinical Development Director, Clermont-Ferrand, France

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Phase 3
Completed
Conditions
Dry Eye Syndromes
Interventions
Device: T2750
Device: Vismed
First Posted Date
2012-04-02
Last Posted Date
2016-04-04
Lead Sponsor
Laboratoires Thea
Target Recruit Count
93
Registration Number
NCT01568593

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Completed
Conditions
Ocular Surface Disease
Palpebral Pathologies
Meibomian Gland Dysfunction
First Posted Date
2012-03-13
Last Posted Date
2015-09-01
Lead Sponsor
Laboratoires Thea
Target Recruit Count
185
Registration Number
NCT01552174
Locations
🇩🇪

Consultation office, Heidelberg, Germany

🇪🇸

USIO Departamento de Oftalmologia Hospital Clínico San Carlos, Madrid, Spain

Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

Not Applicable
Withdrawn
Conditions
Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
Interventions
Device: HYABAK®
Device: HYLO-COMOD®
First Posted Date
2012-03-07
Last Posted Date
2015-09-02
Lead Sponsor
Laboratoires Thea
Registration Number
NCT01546012
Locations
🇩🇪

Augenklinik, Berlin, Germany

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
Primary Open Angle Glaucoma
Interventions
Drug: Prostaglandin
First Posted Date
2011-12-19
Last Posted Date
2024-02-07
Lead Sponsor
Laboratoires Thea
Target Recruit Count
30
Registration Number
NCT01494753

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Phase 2
Completed
Conditions
Seasonal Allergic Conjunctivitis
Interventions
First Posted Date
2011-04-28
Last Posted Date
2012-04-12
Lead Sponsor
Laboratoires Thea
Target Recruit Count
60
Registration Number
NCT01344083
Locations
🇫🇷

Pierre Huguet, Clermont ferrand, France

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
Drug: NAABAK eyedrops
Drug: Saline eyedrops
First Posted Date
2010-09-16
Last Posted Date
2012-01-31
Lead Sponsor
Laboratoires Thea
Target Recruit Count
21
Registration Number
NCT01203540
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of

🇰🇷

Seoul National University Boramae Medical Center, Seoul, Korea, Republic of

Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy

Phase 1
Completed
Conditions
Eyelid Diseases
Interventions
Device: Warming goggles
Device: warm and moist compresses
First Posted Date
2010-08-27
Last Posted Date
2010-12-06
Lead Sponsor
Laboratoires Thea
Target Recruit Count
20
Registration Number
NCT01190397
Locations
🇬🇧

School of Optometry & Vision Sciences, Cardiff, United Kingdom

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

Phase 4
Completed
Conditions
Eyelid Diseases
First Posted Date
2010-08-26
Last Posted Date
2012-10-03
Lead Sponsor
Laboratoires Thea
Target Recruit Count
104
Registration Number
NCT01189474
Locations
🇫🇷

76 Allée des Pins Tranquilles, Hossegord, France

🇫🇷

Clinique du Cours Dillion, Toulouse, France

🇫🇷

Hopital Dupuytren, Limoges, France

and more 26 locations
© Copyright 2025. All Rights Reserved by MedPath